Tandem Melphalan and Autolog. SCT in MM Patients 60 to 70 Years of Age With and Without Induction Chemotherapy

NCT02288741 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

549

Enrollment

OTHER

Sponsor class

Conditions

Multiple Myeloma

Interventions

DRUG: Anthracycline/dexamethasone-based induction chemotherapy
DRUG: Dexamethasone for control of symptoms
DRUG: Tumor-reduction chemotherapy and stem cell mobilization
PROCEDURE: Stem cell apheresis
DRUG: Tandem high-dose chemotherapy (melphalan)
PROCEDURE: Autologous peripheral blood stem cell transplantation

Sponsor

WiSP Wissenschaftlicher Service Pharma GmbH